Search hospitals > Colorado > Englewood
Rocky Mountain Cancer Centers-Greenwood Village
Claim this profileEnglewood, Colorado 80111
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
Conducts research for Adenocarcinoma
134 reported clinical trials
2 medical researchers
Summary
Rocky Mountain Cancer Centers-Greenwood Village is a medical facility located in Englewood, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Adenocarcinoma and other specialties. Rocky Mountain Cancer Centers-Greenwood Village is involved with conducting 134 clinical trials across 324 conditions. There are 2 research doctors associated with this hospital, such as Nicholas DiBella and Robert M. Jotte.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Robert M. JotteGSK Investigational Site3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
11 drugs studied
Clinical Trials running at Rocky Mountain Cancer Centers-Greenwood Village
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Melanoma
Cutaneous Melanoma
Bladder Cancer
Tumors
Skin Cancer
Gastroesophageal Junction Adenocarcinoma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers-Greenwood Village?
Rocky Mountain Cancer Centers-Greenwood Village is a medical facility located in Englewood, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Adenocarcinoma and other specialties. Rocky Mountain Cancer Centers-Greenwood Village is involved with conducting 134 clinical trials across 324 conditions. There are 2 research doctors associated with this hospital, such as Nicholas DiBella and Robert M. Jotte.